Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
5.49
+0.07 (1.20%)
Feb 25, 2026, 2:22 PM EST - Market open
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Perspective Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $12.2, which forecasts a 122.42% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $16.
Price Target: $12.2 (+122.42%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 5 | 5 | 3 | 3 | 3 | 4 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 10 | 10 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $16 | Buy | Initiates | $16 | +191.70% | Feb 19, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +118.78% | Jan 30, 2026 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +100.55% | Jan 30, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +155.24% | Jan 13, 2026 |
| Truist Securities | Truist Securities | Strong Buy Initiates $8 → $12 | Strong Buy | Initiates | $8 → $12 | +118.78% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
1.09M
from 1.45M
Decreased by -24.97%
Revenue Next Year
993.70K
from 1.09M
Decreased by -8.92%
EPS This Year
-1.28
from -1.23
EPS Next Year
-1.34
from -1.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.4M | 1.5M | ||||
| Avg | 1.1M | 993,704 | ||||
| Low | 824,180 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.4% | 34.7% | ||||
| Avg | -25.0% | -8.9% | ||||
| Low | -43.3% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.19 | -1.04 | ||||
| Avg | -1.28 | -1.34 | ||||
| Low | -1.30 | -1.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.